111 related articles for article (PubMed ID: 9498199)
1. [Results of selective venous site-specific catheterization in occult C-cell carcinoma of the thyroid gland].
Cupisti K; Simon D; Dotzenrath C; Goretzki PE; Röher HD
Langenbecks Arch Chir; 1997; 382(6):295-301. PubMed ID: 9498199
[TBL] [Abstract][Full Text] [Related]
2. Surgical management and follow-up of medullary thyroid carcinoma.
Marzano LA; Porcelli A; Biondi B; Lupoli G; Delrio P; Lombardi G; Zarrilli L
J Surg Oncol; 1995 Jul; 59(3):162-8. PubMed ID: 7609522
[TBL] [Abstract][Full Text] [Related]
3. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
4. Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery.
Schott M; Willenberg HS; Sagert C; Nguyen TB; Schinner S; Cohnen M; Cupisti K; Eisenberger CF; Knoefel WT; Scherbaum WA
Clin Endocrinol (Oxf); 2007 Mar; 66(3):405-9. PubMed ID: 17302876
[TBL] [Abstract][Full Text] [Related]
5. Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma.
Abdelmoumene N; Schlumberger M; Gardet P; Roche A; Travagli JP; Francese C; Parmentier C
Br J Cancer; 1994 Jun; 69(6):1141-4. PubMed ID: 8198983
[TBL] [Abstract][Full Text] [Related]
6. Can the early reduction of tumour markers predict outcome in surgically treated sporadic medullary thyroid carcinoma?
Bümming P; Ahlman H; Nilsson B; Nilsson O; Wängberg B; Jansson S
Langenbecks Arch Surg; 2008 Sep; 393(5):699-703. PubMed ID: 18626656
[TBL] [Abstract][Full Text] [Related]
7. A decrease of calcitonin serum concentrations less than 50 percent 30 minutes after thyroid surgery suggests incomplete C-cell tumor tissue removal.
Faggiano A; Milone F; Ramundo V; Chiofalo MG; Ventre I; Giannattasio R; Severino R; Lombardi G; Colao A; Pezzullo L
J Clin Endocrinol Metab; 2010 Sep; 95(9):E32-6. PubMed ID: 20534767
[TBL] [Abstract][Full Text] [Related]
8. Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients.
Yen TW; Shapiro SE; Gagel RF; Sherman SI; Lee JE; Evans DB
Surgery; 2003 Dec; 134(6):890-9; discussion 899-901. PubMed ID: 14668720
[TBL] [Abstract][Full Text] [Related]
9. Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma.
Wang TS; Ocal IT; Sosa JA; Cox H; Roman S
Thyroid; 2008 Aug; 18(8):889-94. PubMed ID: 18651827
[TBL] [Abstract][Full Text] [Related]
10. Reoperation for recurrent or persistent medullary thyroid cancer.
Moley JF; Wells SA; Dilley WG; Tisell LE
Surgery; 1993 Dec; 114(6):1090-5; discussion 1095-6. PubMed ID: 8256212
[TBL] [Abstract][Full Text] [Related]
11. Repeat mediastinal lymph-node dissection for palliation in advanced medullary thyroid carcinoma.
Machens A; Gimm O; Ukkat J; Sutter T; Dralle H
Langenbecks Arch Surg; 1999 Jun; 384(3):271-6. PubMed ID: 10437616
[TBL] [Abstract][Full Text] [Related]
12. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
Cohen R; Campos JM; Salaün C; Heshmati HM; Kraimps JL; Proye C; Sarfati E; Henry JF; Niccoli-Sire P; Modigliani E
J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
Costante G; Meringolo D; Durante C; Bianchi D; Nocera M; Tumino S; Crocetti U; Attard M; Maranghi M; Torlontano M; Filetti S
J Clin Endocrinol Metab; 2007 Feb; 92(2):450-5. PubMed ID: 17119000
[TBL] [Abstract][Full Text] [Related]
14. [Medullary thyroid cancer: review of 28 patients].
Pulgar B D; Jans B J; Petric G M; León R A; Camus A M; Goñi E I; Domínguez C F; Droppelmann M N; Claure S R; González D H
Rev Med Chil; 2013 Nov; 141(11):1395-401. PubMed ID: 24718465
[TBL] [Abstract][Full Text] [Related]
15. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
[TBL] [Abstract][Full Text] [Related]
16. [The concept of "microsurgical" technique in medullary thyroid carcinoma].
Mann B; Buhr HJ; Faulhaber J
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():720-3. PubMed ID: 9931710
[TBL] [Abstract][Full Text] [Related]
17. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.
Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E;
Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of reoperations for medullary thyroid carcinoma.
Fialkowski E; DeBenedetti M; Moley J
World J Surg; 2008 May; 32(5):754-65. PubMed ID: 18188643
[TBL] [Abstract][Full Text] [Related]
19. Improved results of cervical reoperation for medullary thyroid carcinoma.
Moley JF; Dilley WG; DeBenedetti MK
Ann Surg; 1997 Jun; 225(6):734-40; discussion 740-3. PubMed ID: 9230814
[TBL] [Abstract][Full Text] [Related]
20. [Surgical management of medullary thyroid carcinoma. Personal experience].
Geraci G; Pisello F; Tornambè A; Platia L; Sciumè C; Li Volsi F; Cupido F; Modica G
G Chir; 2007 Oct; 28(10):385-9. PubMed ID: 17915054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
